These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23372609)

  • 1. Avanafil for the treatment of erectile dysfunction: initial data and clinical key properties.
    Kedia GT; Uckert S; Assadi-Pour F; Kuczyk MA; Albrecht K
    Ther Adv Urol; 2013 Feb; 5(1):35-41. PubMed ID: 23372609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphodiesterase type 5 inhibitors as a treatment for erectile dysfunction: Current information and new horizons.
    Ferguson JE; Carson CC
    Arab J Urol; 2013 Sep; 11(3):222-9. PubMed ID: 26558086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Avanafil: A comprehensive drug profile.
    Al-Majed AA; AlKhairallah A; Attwa MW; Alkahtani HM; El-Azab AS; Abdel-Aziz AA; Alkhider A; Hassan SB; Bakheit AH
    Profiles Drug Subst Excip Relat Methodol; 2024; 49():115-151. PubMed ID: 38423706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A real-world pilot study assessing treatment satisfaction with avanafil in patients with erectile dysfunction.
    Tsai PJ; Hung SY; Lee TH; Jiann BP
    Sex Med; 2024 Feb; 12(1):qfae001. PubMed ID: 38327712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphodiesterase 5 inhibitors: preclinical and early-phase breakthroughs for impotence treatments.
    Melchiode Z; Nguyen T; Dawood O; Bobo GA; Hellstrom WJG
    Expert Opin Investig Drugs; 2023; 32(7):635-642. PubMed ID: 37507822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting phosphodiesterase 5 as a therapeutic option against myocardial ischaemia/reperfusion injury and for treating heart failure.
    Korkmaz-Icöz S; Radovits T; Szabó G
    Br J Pharmacol; 2018 Jan; 175(2):223-231. PubMed ID: 28213937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alprostadil cream in the treatment of erectile dysfunction: clinical evidence and experience.
    Cuzin B
    Ther Adv Urol; 2016 Aug; 8(4):249-256. PubMed ID: 27928427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sildenafil 4.0-Integrated Synthetic Chemistry, Formulation and Analytical Strategies Effecting Immense Therapeutic and Societal Impact in the Fourth Industrial Era.
    Ouranidis A; Tsiaxerli A; Vardaka E; Markopoulou CK; Zacharis CK; Nicolaou I; Hatzichristou D; Haidich AB; Kostomitsopoulos N; Kachrimanis K
    Pharmaceuticals (Basel); 2021 Apr; 14(4):. PubMed ID: 33920975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and evaluation of radioiodinated avanafil: A novel potential radiopharmaceutical for the diagnostic evaluation of erectile dysfunction.
    El-Kawy OA; Ibrahim IT; Shewatah HA; El-Azony KM
    Appl Radiat Isot; 2022 May; 183():110160. PubMed ID: 35228134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PDE5 inhibitors: considerations for preference and long-term adherence.
    Smith WB; McCaslin IR; Gokce A; Mandava SH; Trost L; Hellstrom WJ
    Int J Clin Pract; 2013 Aug; 67(8):768-80. PubMed ID: 23869678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Avanafil for erectile dysfunction.
    Kyle JA; Brown DA; Hill JK
    Ann Pharmacother; 2013 Oct; 47(10):1312-20. PubMed ID: 24259695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avanafil for the treatment of erectile dysfunction. An updated review.
    Egui-Rojo MA; Moncada-Iribarren I; Carballido-Rodríguez J; Martínez-Salamanca JI
    Arch Esp Urol; 2014 Dec; 67(10):839-47. PubMed ID: 25582903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis.
    Yuan J; Zhang R; Yang Z; Lee J; Liu Y; Tian J; Qin X; Ren Z; Ding H; Chen Q; Mao C; Tang J
    Eur Urol; 2013 May; 63(5):902-12. PubMed ID: 23395275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Avanafil for the Treatment of men With Erectile Dysfunction: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Li J; Peng L; Cao D; He L; Li Y; Wei Q
    Am J Mens Health; 2019; 13(5):1557988319880764. PubMed ID: 31672076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Therapeutic Confirmatory Study to Evaluate the Safety and Efficacy of Avanafil in Korean Patients with Erectile Dysfunction.
    Park HJ; Kim SW; Kim JJ; Lee SW; Paick JS; Ahn TY; Park K; Park JK; Park NC
    J Korean Med Sci; 2017 Jun; 32(6):1016-1023. PubMed ID: 28480661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Avanafil for the treatment of erectile dysfunction.
    Zurawin JL; Stewart CA; Anaissie JE; Yafi FA; Hellstrom WJ
    Expert Rev Clin Pharmacol; 2016 Sep; 9(9):1163-70. PubMed ID: 27416913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The safety and efficacy of Avanafil, a new 2(nd) generation PDE5i: comprehensive review and meta-analysis.
    Corona G; Rastrelli G; Burri A; Jannini EA; Maggi M
    Expert Opin Drug Saf; 2016; 15(2):237-47. PubMed ID: 26646748
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.